Twist, Biotia introduce new NGS-based SARS-CoV-2 assay for research use
The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus
The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus
From sample prep to downstream analysis, discover the products making a difference for other scientists in your field
Watch world-leading scientists and industry experts present the latest advances and emerging trends in biopharma, online December 8-10
Watch this on-demand webinar with Dr. Petter Brodin to learn about new insights into the immune response to SARS-CoV-2
Learn how microbiological quality control tests at Coca-Cola ensure consumer safety
All the talks and resources exploring the latest research and methods in the field are now available free and on demand - but for a limited time only
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection
Susie Harborth explores what it takes to be a scientist entrepreneur and highlights the technology driving innovation in bioscience